Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sarcoidosis: a long-term follow up study.

A G Chappell1, W Y Cheung, H A Hutchings

  • 1Department of Medicine, Princess of Wales Hospital, Bridgend.

Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|August 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial.

Nature medicine·2024
Same author

A study protocol for a double-blind randomised placebo-controlled trial evaluating the efficacy of carrageenan nasal and throat spray for COVID-19 prophylaxis-ICE-COVID.

Trials·2022
Same author

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.

Immunotherapy advances·2022
Same author

Construct validity of the anglicised FACE-Q skin cancer module.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2021
Same author

Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

Quality of life in a real-world study of patients with metastatic colorectal cancer treated with trifluridine/tipiracil.

Current oncology (Toronto, Ont.)·2020

This study on sarcoidosis found that early-stage disease has a good prognosis, with most patients experiencing resolution. Advanced sarcoidosis, however, can lead to poor outcomes, even with treatment.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Epidemiology

Background:

  • Sarcoidosis is an inflammatory disease affecting multiple organs, commonly the lungs.
  • Understanding sarcoidosis progression and prognosis is crucial for patient management.
  • This study examines a long-term cohort of sarcoidosis patients within a defined population.

Purpose of the Study:

  • To investigate the occurrence, presentation, clinical features, disease course, and prognosis of sarcoidosis.
  • To analyze the outcomes of patients managed by a single physician over 30 years.
  • To compare findings with existing literature on sarcoidosis prognosis.

Main Methods:

  • Retrospective review of 212 patient records from 1965-1996.
  • Utilized a structured data collection form for detailed case information.

Related Experiment Videos

  • Employed postal questionnaires and death certificate analysis for survival and cause of death data.

    • Main Results:

    • Sarcoidosis diagnosed clinically in 63/212 cases, histologically confirmed in 149/212.
    • Pulmonary involvement observed in 192 cases; Stages 1 and 2 showed >80% resolution, Stage 3 had 50% resolution.
    • Two distinct patterns of advanced disease: stable infiltration/fibrosis or steroid-refractory progressive fibrosis with poor prognosis.

    Conclusions:

    • Stage 1 sarcoidosis confirms a good prognosis.
    • Fewer patients presented with Stages 2 and 3, exhibiting better prognoses than previously reported.
    • A small subset of patients developed steroid-refractory progressive fibrosis, but overall sarcoidosis mortality was low.